Quantifying Nasal Drug Delivery in Humans Through Translational Evidence From Pre-Clinical to Clinical Settings
Time: 9:30 am
day: Day 2
Details:
- Exploring advanced imaging modalities and biomarker analyses used to measure drug distribution and quantify the extent of nasal delivery in human subjects
- Discussion on the critical pathways and methodologies that bridge preclinical findings with clinical applications
- Presentation of case studies demonstrating successful nasal delivery, highlighting key results, challenges faced, and lessons learned
